Cardinal Health (CAH): Freestone Grove Partners LP reduced its stake -212K shares
Freestone Grove Partners LP reduced its stake in Cardinal Health, per its Q4 2025 13F.
- 252K
- Shares reported · -212K vs prior quarter
- 0.37%
- Disclosed portfolio weight
- $51.8M
- Reported value
- Holdings as of
- Dec 31, 2025
- Filed
- Feb 17, 2026
What stands out in this filing
- 464,570 shares in Q3 2025, 252,191 now (−45.7% in share count).
- Reported at $51.8M, 0.37% of the portfolio value in this 13F filing.
- 62 other tracked managers reported the same kind of change for Q4 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 26, 2025FDARecall: Chest Drainage Units and Accessories: Product Code Description 1. 8888571562 Cardinal Health Sentinel Seal CDU 2. 8888571513 Cardinal Health Sentinel Seal CDU,…
- Jan 15, 2026Federal contract · $1.4M obligatedDepartment of Veterans Affairs awarded Cardinal Health: $1.39M obligated to date
- Jan 21, 20265% stakeBlackRock Portfolio Management LLC reported a passive stake (13G) of 3.8%
- Jan 27, 2026Federal contract · $1.9M obligatedDepartment of Veterans Affairs awarded Cardinal Health: $1.88M obligated to date
- Feb 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Feb 6, 2026InsiderDirector sold ~$919K of CAH shares in the open market
What came next
- Feb 18, 2026InsiderCFO sold ~$525K of CAH shares in the open market
- Feb 27, 2026FDARecall: Cardinal Health Monoject Tuberculin Syringe, 1 mL Luer Lock, Catalog Number 1180100777
- Feb 27, 2026Insider · 1 personInsiders: 2 sales (~$627K)
- Mar 2, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 2, 2026, Mary Scherer, Senior Vice President and Chief Accounting Officer, notified Cardinal Health, Inc. (the “Company”) that she intends to retire in February 2027.”
- Mar 2, 2026FDARecall: Webcol Alcohol Prep pad (70% isopropyl alcohol) 2 ply, 200 count boxes, Cardinal Health 200 LLC 3651 Birchwood Drive, Waukegan, IL 60085.
- Mar 17, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 17, 2026, Gregory B. Kenny notified Cardinal Health, Inc. (the “Company”) of his decision to retire from the Board of Directors (the “Board”), all committees thereof and from his position as Board Chair, effective March 20, 2026.”
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 28, 2026FDAFDA device clearance: Cardinal Health Poly Reinforced Surgical Gown
- Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.8%
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- Apr 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- May 7, 2026Government · Federal Register notice365 Retail Markets and Cantaloupe; Analysis of Proposed Agreement Containing Consent Orders To Aid Public Comment
- May 26, 2026Federal contract · $2.5M obligatedDepartment of Veterans Affairs awarded Cardinal Health: $2.53M obligated to date
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Cardinal Health
For Cardinal Health, OQRO holds 2 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CAH page.
How this filing works
Explore the data
Common questions
What does this filing report about Cardinal Health (CAH) stock?
Freestone Grove Partners LP reduced its stake in Cardinal Health, per its Q4 2025 13F. Now 252K shares, $51.8M reported value, 0.37% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Dec 31, 2025. Filed: Feb 17, 2026.
What stands out in this filing?
464,570 shares in Q3 2025, 252,191 now (−45.7% in share count). Reported at $51.8M, 0.37% of the portfolio value in this 13F filing. 62 other tracked managers reported the same kind of change for Q4 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Cardinal Health recently?
For Cardinal Health, OQRO holds 2 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the CAH page.
Does this mean CAH stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Cardinal Health
- SEC Form 13F-HRNov 16, 2026
- SEC Schedule 13GNov 16, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- SEC Form 4Aug 21, 2026
- SEC Form 4Aug 21, 2026
Everything OQRO holds on this company is on its CAH page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
